Valade, Sandrine http://orcid.org/0000-0001-6834-0624
Darmon, Michael
Zafrani, Lara
Mariotte, Eric
Lemiale, Virginie
Bredin, Swann
Dumas, Guillaume
Boissel, Nicolas
Rabian, Florence
Baruchel, André
Madelaine, Isabelle
Larghero, Jérôme
Brignier, Anne
Lengliné, Etienne
Harel, Stéphanie
Arnulf, Bertrand
Di Blasi, Roberta
Thieblemont, Catherine
Azoulay, Elie
Article History
Received: 18 March 2022
Accepted: 17 June 2022
First Online: 17 August 2022
Declarations
:
: This study was approved by a local ethic committee (Société de Réanimation de Langue Française, CE SRLF 19–04). According to French law, need for informed consent was waived. In accordance with the French legislation, the database was declared to the CNIL (“Commission Nationale de l’Informatique et des Libertés”) (Number 2221124).
: Not applicable.
: SV reports non-financial support from Pfizer, personal fees from Gilead-Kite, personal, personal fees from Sanofi, outside the submitted work. AB reports non-financial support from Gilead, personal fees from BMS-Celgene, personal, personal fees from Janssen outside the submitted work. JL reports non-financial support from Gilead, personal fees from Novartis, Gilead and BMS, outside the submitted work. CT reports non-financial support from BMS-Celgene, Janssen, Gilead, personal fees from Gilead, Kite, Takeda, Novartis, BMS-Celgene, Astrazeneca, Janssen, Sanofiu and Roche, outside the submitted work. EM reports personal fees from Sanofi, outside the submitted work. EA reports personal fees from Gilead, personal fees from Pfizer, personal fees from Baxter, personal fees from Alexion, outside the submitted work. MD reports grants from MSD, personal fees from Astelas, personal fees and non-financial support from Gilead-Kite, personal fees from Sanofi, outside the submitted work. LZ reports grants from Jazz Pharmaceuticals, outside the submitted work. Other authors declare that they have no competing interests.